Laboratory Information System Market to Reach USD 3,620.3 Million by 2034 at a 6.0% of CAGR

Laboratory Information System Market
Laboratory Information System Market

The global laboratory information system (LIS) market is on a growth trajectory, with the market size expected to reach USD 2,166.3 million in 2024, reflecting a year-on-year growth rate of 6.0%. Over the next decade, the market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, attaining a valuation of approximately USD 3,620.3 million by 2034.

Key Takeaways:

  • Market Valuation: The laboratory information system market is set to achieve a valuation of USD 2,166.3 million in 2024, up from previous levels.
  • Growth Forecast: The market is projected to grow at a CAGR of 5.3% over the next decade, reaching USD 3,620.3 million by 2034.
  • Demand Drivers: The growing demand for cloud-based laboratory information systems is a major driver, due to their enhanced accessibility, scalability, and cost-effectiveness. The cloud-based segment is expected to advance at a CAGR of 6.0% from 2024 to 2034.

The anticipated growth reflects the increasing adoption of advanced LIS solutions and the shift toward cloud-based systems, which offer significant advantages in modern laboratory management.

Germany dominates the European market for laboratory information systems, having accounted for a 28.2% market share in 2014, followed by France. The U.K is expected to become a major market for laboratory information systems (LIS) in the coming years.

The European laboratory information systems market is segmented on the basis of products, types, components, delivery mode, end users, and countries. The product segment is divided into standalone LIS and integrated LIS. The types included in the report are clinical LIS and anatomical LIS. The components covered in the report are services and software. On-premise, remotely-hosted, and cloud-based are delivery modes discussed in the report. The end users’ segment is further classified into clinical diagnostic laboratories, hospitals, anatomical pathology laboratories, blood banks, and molecular diagnostic laboratories. The countries such as Germany, Italy, Spain, U.K., and France would experience tremendous growth.

The European Commission’s new framework, Horizon 2020 has been the largest ever research and innovation programme in Europe for various fields including life sciences with a budget of $95 billion (€77 billion) from 2014-2020. In October 2017, The European Commission announced its plans to invest $37 billion (€30 billion) of this fund during 2018-2020 including $2.5 billion (€2 billion) to support Open Science, and $740 million (€600 million) for the European Open Science Cloud, European data infrastructure and high-performance computing. Horizon 2020 opened funding opportunities for future and emerging technologies and ICT Work Programme for life science researchers. Thus, increasing R&D activities and government funding will ultimately boost the demand for effective data management and hence drive the laboratory informatics market in Europe.

Competitive Landscape

Top companies in the laboratory information systems market are constantly releasing new products to increase their market share. They are bolstering their global reach through mergers, partnerships, and acquisitions.

Recent Developments

In September 2022, McKesson Corporation signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.

Key Companies Profiled: 

ECerner Corp, Evident, McKesson, Medical Information Technology, Epic Systems Corporation, SCC Soft Computer, Roper Technologies Inc., CompuGroup Medical, and LabWare

Key Segments Covered in the Laboratory Information Systems Industry Analysis

By Components:

  • Software
  • Hardware
  • Services

By Delivery Mode:

  • On-Premise
  • Cloud-Based

By End User:

  • Hospitals
  • Clinics
  • Independent Laboratories
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hyperbaric Oxygen Therapy Devices Market to Reach USD 6.86 Billion by 2033 at a 7.0% of CAGR

Hyperbaric Oxygen Therapy Devices Market
Hyperbaric Oxygen Therapy Devices Market

The global hyperbaric oxygen therapy (HBOT) devices market is poised for substantial growth, with an expected valuation of USD 3.47 billion in 2023. Fueled by increasing applications in wound healing and the rising number of athletes seeking advanced therapeutic solutions, the market is projected to expand at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2033, reaching approximately USD 6.86 billion by the end of the forecast period.

Key Takeaways:

  • Market Valuation: The hyperbaric oxygen therapy devices market is expected to be valued at USD 3.47 billion in 2023.
  • Growth Forecast: The market is projected to grow at a robust CAGR of 7.0%, reaching around USD 6.86 billion by 2033.
  • Growth Drivers: The increasing use of HBOT for wound healing and its rising popularity among athletes are major factors driving market demand.

The forecasted growth reflects a rising recognition of hyperbaric oxygen therapy’s benefits and an expanding market as more individuals and healthcare facilities adopt these advanced treatment technologies.

Despite having a promising future, the hyperbaric oxygen therapy equipment market faces some challenges. One significant obstacle is the high initial cost of setting up hyperbaric chambers and related equipment. The high cost associated with hyperbaric oxygen therapy facilities limits their adoption, especially in underfunded healthcare facilities. Furthermore, the widespread use of hyperbaric oxygen therapy devices is hindered in some regions by stringent regulatory requirements and restrictive payment practices. These issues need to be fixed in order to ensure that a wider spectrum of patients can get therapy and to completely reap the benefits of HBOT.

Using cutting-edge digital technology is one of the biggest developments in the hyperbaric oxygen therapy device market. Hyperbaric chambers equipped with Internet of Things connectivity and remote monitoring features enable medical professionals to quickly modify treatment parameters and monitor patients’ progress. Artificial intelligence and machine learning are now being researched as ways to improve hyperbaric oxygen therapy’s accuracy and efficacy. Additionally, because of its ease of use and versatility, portable hyperbaric oxygen therapy equipment is increasingly being used for home-based treatments.

Key Companies Profiled:

  • ETC BioMedical Systems
  • Fink Engineering Pvt. Ltd.
  • Gulf Coast Hyperbarics Inc.
  • HAUX-LIFE-SUPPORT GmbH
  • Hearmec Co. Ltd.
  • Hyperbaric SAC
  • IHC Hytech B.V.
  • OxyHeal Health Group
  • Sechrist Industries, Inc.
  • SOS Medical Group, Ltd.

Key Segments Covered in the Hyperbaric Oxygen Therapy Devices Industry Analysis:

By Type of Products:

  • Mono-place HBOT Devices
  • Multi-place HBOT Devices
  • Topical HBOT Devices

By Application:

  • Wound Healing
  • Decompression Sickness
  • Infections
  • Gas Embolism
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific

A Old Full  – Report Analysis

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Traditional Toys and Games Market From 2023 to 2033 : Trends, Challenges, and Competition

In 2022, the global traditional toys and games market was valued at approximately USD 93.85 billion. A significant driver of this growth is the rising popularity of building toys among adults, which enhances their learning abilities. This trend is expected to contribute to the market reaching an estimated USD 139.01 billion by 2033, with a compound annual growth rate (CAGR) of 3.6% from 2023 to 2033.

The traditional toys and games market, with its rich history and enduring appeal, continues to captivate consumers worldwide. This sector encompasses a wide range of products, from classic wooden toys to timeless board games, each contributing to its substantial global presence. This blog delves into the primary drivers of the traditional toys and games market, the challenges it faces, and the competitive landscape that shapes its evolution.

Market Overview and Growth Drivers

The traditional toys and games market is projected to grow from approximately $90 billion in 2023 to $130 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 3.5%. This growth is driven by several key factors:

  1. Nostalgia and Heritage Appeal: Traditional toys and games hold a significant nostalgic value for both parents and children. The revival of classic toys such as wooden trains and handcrafted dolls is driven by a desire to reconnect with simpler times and preserve cultural heritage. This trend is particularly pronounced in developed regions like North America and Europe.
  2. Educational Value: Traditional toys are increasingly recognized for their educational benefits. Products like puzzles and building blocks are praised for their ability to enhance cognitive skills, motor development, and problem-solving abilities in children. Educational institutions and parents alike are increasingly incorporating these toys into learning environments.
  3. Eco-Friendly Trends: As environmental consciousness rises, there is a growing preference for eco-friendly toys. Traditional toys, often made from sustainable materials like wood and organic fabrics, align with this trend. The push for greener products is driving demand for toys that are both environmentally friendly and durable.
  4. Personalization and Craftsmanship: There is a rising demand for personalized and handcrafted toys. Artisanal and bespoke toys offer a unique touch that mass-produced items cannot match, catering to a market segment that values individuality and quality over quantity.

Challenges in the Traditional Toys and Games Market

  1. Competition from Digital Alternatives: One of the primary challenges facing the traditional toys and games market is the intense competition from digital and electronic toys. Video games, interactive apps, and other digital entertainment options offer high-tech features and engaging experiences that traditional toys sometimes struggle to match.
  2. Changing Consumer Preferences: As technology advances, consumer preferences are evolving. There is a growing inclination towards toys that incorporate technological elements, such as augmented reality or smart features. Traditional toys may face difficulties in competing with these high-tech innovations, requiring manufacturers to adapt and innovate to stay relevant.
  3. Regulatory and Safety Standards: Traditional toy manufacturers must navigate stringent regulatory and safety standards. Compliance with these regulations, which are designed to ensure product safety and quality, can be challenging and costly. This is particularly relevant for toys intended for young children, where safety is of paramount importance.
  4. Supply Chain and Production Costs: The production and distribution of traditional toys can be impacted by supply chain disruptions and rising production costs. Fluctuations in the prices of raw materials and transportation challenges can affect profitability and pricing strategies, potentially impacting market growth.

Market Competition

  1. Key Players and Market Dynamics: The traditional toys and games market is characterized by the presence of both established and emerging players. Major companies such as Lego, Hasbro, and Mattel have a significant influence on the market, leveraging their brand recognition and extensive product lines. Additionally, there are numerous smaller, niche companies specializing in handcrafted or educational toys, adding diversity to the competitive landscape.
  2. Innovation and Differentiation: To stay competitive, companies in the traditional toys and games market must focus on innovation and differentiation. This includes incorporating new designs, materials, and functionalities into their products while maintaining the core characteristics that make traditional toys appealing. For instance, some manufacturers are combining traditional play patterns with modern themes or incorporating interactive elements to enhance the appeal of their products.
  3. Marketing and Distribution Strategies: Effective marketing and distribution strategies are crucial for success in the traditional toys and games market. Companies must employ creative marketing campaigns that highlight the unique benefits of their products and leverage various distribution channels, including online platforms and specialty stores, to reach their target audiences effectively.
  4. Global Market Trends: Global trends also play a role in shaping market competition. For example, the rise of emerging markets presents new opportunities for growth. Companies looking to expand their reach must navigate different cultural preferences and regulatory environments, adapting their products and strategies to meet diverse consumer needs.

Key Segments Profiled in the Global Traditional Toys and Games Market

By Product Type:

  • Games/Puzzles
  • Infants/Toddlers/Preschool Toys
  • Plush
  • Outdoor & Sports Toys
  • Model Vehicles
  • Dolls
  • Construction sets
  • Art and Crafts
  • Remote control toys
  • Educational toys
  • Dress up and role play
  • Ride on Vehicles

By Material:

  • Plastic
  • Textile
  • Metal
  • Wood

By Age Group:

  • 0 to 18 months
  • 19 to 36 months
  • 3 to 4 years
  • 5 to 8 years
  • 8 to 10 years
  • 11 to 14 years

By Sales Channel:

  • Hyper/Supermarket
  • Online
  • Franchised Outlets
  • Departmental Stores
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Thermal Printing Market to rise at a 7.8% CAGR from 2023 to 2033; reaching US$ 28.4 billion: FMI Study

The global thermal printing market is witnessing a remarkable growth trajectory, estimated to be valued at US$ 13.3 billion in 2023 and projected to reach a staggering US$ 28.4 billion by 2033, showcasing a robust CAGR of 7.8% over the forecast period from 2023 to 2033.

In an age of technological evolution, the demand for thermal printers is soaring due to their durability and reliability, especially in challenging environments and high-volume production settings. This rapid expansion is anticipated to continue throughout the forecast period, driven by the ever-growing need for efficient printing solutions.

Key Takeaways: Thermal Printing Market

Rising at above 7.8% CAGR between 2023 and 2033, the thermal printing market will register impressive growth through the forecast period Presence of a thriving retail sector will continue driving the U.S. market, enabling it to account for over 86% of sales in North America Increasing demand in healthcare, retail, and other industries will enable the U.K. market to register over 5% y-o-y growth in 2023 Germany and France are expected remain highly lucrative markets for thermal printing sales in Europe Focus on digital transformation has been enabling sales in China, while Japan and South Korea remain lucrative markets within East Asia

The global thermal printing market’s growth trajectory is a testament to the surging demand for resilient printing solutions. As industries across the spectrum recognize the advantages of thermal printing, the market is poised for an impressive expansion. Key factors propelling this surge include:

  • Incorporation of Thermal Printers in Retail: The retail industry’s adoption of thermal printers is a significant catalyst for market growth. Many experts envision thermal printing as the future of commerce, given its speed, cost-effectiveness, and suitability for a wide array of applications.

Drivers and Opportunities Fueling Thermal Printing Market Expansion

The thermal printing market’s upward trajectory is underpinned by several driving forces that are shaping its evolution:

  • Rising Technological Advancements: The printing industry’s continuous embrace of cutting-edge technologies is a key driver. Incorporating innovative and sophisticated printing solutions across diverse applications is expected to fuel the market’s growth in the years ahead.
  • Durable and Reliable Solutions for Harsh Environments: The demand for thermal printers that can withstand challenging conditions is on the rise. Industries such as manufacturing, logistics, and healthcare are seeking durable and reliable printing options, driving the market’s expansion.

Competition Analysis and Regional Insights Shaping the Industry Landscape

As the global thermal printing market evolves, competition among key players is intensifying. Regional trends and insights provide valuable perspectives on the industry’s dynamics:

  • Region-wise Insights: Different regions are witnessing varying rates of adoption and market penetration for thermal printing solutions. Geographical nuances and regional preferences are influencing market growth trajectories.
  • Category-wise Insights: The versatility of thermal printing technology is reflected in its applications across various sectors. From labeling and packaging to ticketing and receipt printing, thermal printers are finding diverse uses, contributing to the market’s expansion.

As the global thermal printing market continues to surge, it is evident that its growth is driven by a confluence of factors, including technological innovation, industry-specific demands, and regional dynamics. With a projected CAGR of 7.8%, the market is poised for significant expansion, cementing its role as a vital component of modern printing solutions.

Key Segments profiled in the Thermal Printing Industry Survey

Printer Type:

  • Barcode Printer
  • POS Printer
  • Kiosk & Ticket Printer
  • RFID Printer
  • Card Printer

Printing Technology:

  • Direct Thermal
  • Thermal Transfer
  • Dye Diffusion Thermal Transfer

Industry:

  • Retail & Wholesale
  • Transportation & Logistics
  • Healthcare
  • Travel & Hospitality
  • Media & Entertainment
  • Manufacturing
  • Government
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Companion Animal Drugs Market to Reach USD 59.2 Billion by 2033 at a 4.4% of CAGR

Companion Animal Drugs Market
Companion Animal Drugs Market

The global companion animal drugs market is poised for significant growth, with a forecasted market valuation of USD 59.2 billion by the end of 2033. This represents a substantial increase from USD 36.7 billion recorded in 2022. The market is anticipated to expand at a compound annual growth rate (CAGR) of 4.4% throughout the forecast period.

The expansion of the companion animal drugs market is driven by several factors, including the growing number of pet owners globally, increased awareness of animal health, and advancements in veterinary pharmaceuticals. As pets increasingly become integral members of families, there is a rising demand for high-quality, effective medications to address a wide range of health issues and enhance their quality of life.

Key Takeaways:

  • Market Valuation: The companion animal drugs market is projected to grow from USD 36.7 billion in 2022 to USD 59.2 billion by 2033.
  • Growth Rate: The market is anticipated to expand at a CAGR of 4.4% over the forecast period.
  • Drivers of Growth: Increasing pet ownership, advancements in veterinary medicine, and a rising focus on animal health and wellness are key factors fueling this market expansion.

This promising outlook highlights the growing importance of pharmaceuticals in the care and health management of companion animals, reflecting a heightened focus on enhancing the quality of life for pets globally.

Increasing Urbanization and Growing Affluence in Developing Countries to Benefit the Market
Increasing urbanization level and growing affluence, especially in developing countries, have been driving the adoption of pets, thus leading to increased demand for healthcare products for pets such as companion animal drugs. Continued urbanization has also resulted in increasing prevalence of various diseases such as allergies, lower appetite, reduced energy and behavioral anxieties among small companion animals. This has been driving the demand for innovative classes of medicines such as companion animal drugs.

Upcoming Therapeutic Innovations in Pet Care to Aid Market Growth
Besides traditional drugs, animal health companies have also been investing in smart diagnostic care to help prevent diseases before the actual onset. Companies are also trying to develop generic capabilities to demonstrate bioequivalence to reference prescription drugs in the companion animal drugs market, as many key drugs no longer benefit from intellectual property protection. The development of new vaccines and medications for animals are expected to support the growth of the companion animal drugs market over the forecast period.

Increasing R&D activities and shorter drug-lifecycle are playing an important role in the growth of the companion animal drugs market. Innovations in companion animal drugs are easier and sustainable for a longer period of time, while R&D cycle time are shorter (~ three years) in the Companion Animal Healthcare (CAH) industry as compared to human health, ranging between seven and 15 years for other drugs. This increases return on investment in companion animal drugs and leads to faster profits for the market players.

Collaborative Ventures to Promote the Companion Animal Drugs Market Growth
Collaborative ventures such as One Health promotes unification of veterinary and medical sciences, leading to better disease surveillance, control and education, especially for companion animals such as dogs and cats. One Health venture enables identification of alteration in infection travelling patterns. The patterns are changing mostly in case of parasites due to change in climate and increasing host-vector interactions. Some organizations helping in monitoring of One Health in companion animals are Companion Animal Parasite Council and European Scientific Counsel Companion Animal Parasites.

Such ventures are expected to complement the growth of the companion animal drugs market.

Low Awareness of Animal Diseases to Hamper the Companion Animal Drugs Market Growth
In many developing countries, people lack awareness regarding certain serious companion animal diseases as opposed to livestock diseases, which are more regularly monitored. This is primarily true with regards to pet vaccinations, which is a mandatory requirement for up to three years. Additionally, parasitic medications for companion animals and livestock are different. Lack of awareness with regards to differentiation of these medication varieties leads to adverse drug side effects and thus low administration of companion animal medications. Such factors are likely to create a hindrance in the growth of the companion animal drugs market.

Also, majority of animal healthcare drugs have limited scope for patent extension, primarily due to drug portfolios dominated by drugs that have crossed maturity, which in turn is expected to deter the growth of the companion animal drugs market over the forecast period.

Competitive Landscape

Extensive mergers and acquisitions, product portfolios, geographical expansions, and collaborative research initiatives are some of the strategies undertaken by the leading players. Established players in this market have made alliances with different companies to increase their market reach and social media presence. Some well-established players in the US companion animal drug specialty market are:

  • Merck Animal Health
  • Elanco
  • Zoetis
  • Vetiquinol S.A.
  • Virbac, Inc.
  • Norbrook Inc.
  • Dechra Pharmaceuticals
  • Patterson Companies, Inc.
  • Vedco Inc.
  • Covetrus
  • MWI Animal Health
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • Ellevet Sciences

Recent Developments

  • In 2017, Zoetis emerged as a leading player with the highest share of compassion animal specialty drugs, as the company has a considerable and significant market presence, a diverse portfolio of product offerings, and an acute strategic perspective which includes M&As, such as the acquisition of Abaxis in 2018.
  • In July 2019, Zoetis and Colorado state university made an agreement to establish a research lab for the development of immunotherapies for veterinary patients.
  • In August 2020, Elanco Animal Health Incorporatedannounced that it has acquired Bayer Animal Health. The transaction was valued at USD 6.89 billion. This development helped the company to expand itself in the durable animal health industry.

Key Players in the Companion Animal Drugs Market:

  • Zoetis Inc.
  • Merck & Co, Ltd.
  • Bayer AG
  • Elanco
  • Boehringer Ingelheim GmbH (Merial)
  • Virbac Animal Health
  • Ceva Santè Animale

Key Segments Covered in Companion Animal Drugs Industry Research

Product:

  • Antibiotics
  • Anti-inflammatory
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Skin Care Products
  • Vaccines

Distributional Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

A Old Full  – Report Analysis

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Wearable Computing Devices Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

The global wearable computing devices market is poised for remarkable growth, surpassing the milestone of US$ 44.2 billion in 2023.

With a projected CAGR of 19.3%, the market is set to soar to a staggering US$ 258.87 billion by 2033, showcasing its immense potential and promising opportunities for industry players.

The wearable computing devices market is experiencing significant growth driven by the surging demand for health monitoring.

With an increasing focus on personal well-being, consumers are adopting wearable devices such as smart watches to track their fitness activities, monitor vital signs, and manage their overall health.

These devices offer a wide range of features, including real-time data tracking, notifications, and seamless integration with smart phones, making them versatile and appealing to a broad audience. Rapid technological advancements, such as improved sensors and longer battery life, have further accelerated market expansion.

With the convergence of fashion and technology, smart watches have become popular, leading the market and driving innovation in the wearable computing devices industry.

Wearable computing devices are increasingly being integrated with healthcare systems, creating new opportunities for remote patient monitoring and personalized healthcare.

Healthcare professionals can remotely monitor patients’ health conditions, collect real-time data, and provide timely interventions. The integration of wearable devices with electronic health records and telemedicine platforms has improved the efficiency and effectiveness of healthcare delivery.

The wearable computing devices market presents exciting opportunities in advanced healthcare monitoring, IoT applications, and potential integration with augmented reality and virtual reality technologies.

Wearable devices can seamlessly connect and interact with other IoT devices, creating a network of interconnected smart devices. This opens up opportunities for enhanced user experiences, smart home integration, and personalized services based on user preferences and habits.

As wearable devices collect sensitive personal health and activity data, ensuring data security and privacy becomes paramount. Manufacturers and developers must implement robust data protection measures to safeguard user information from unauthorized access or breaches.

Despite the increasing popularity of wearable devices, there are still challenges in achieving widespread user adoption and long-term engagement. Ensuring user-friendly interfaces, meaningful insights from data, and valuable functionalities are vital for driving sustained user interest and engagement.

Key Takeaways:

  • During the forecast period, the market for wearable computing devices in China is expected to secure an impressive CAGR of 23.2%.
  • The market in India is predicted to advance at a robust CAGR of 25.4% from 2023 to 2033, showcasing significant growth potential.
  • The United Kingdom’s wearable computing devices industry is likely to progress with a steady CAGR of 16.5% during the projected period.
  • North America took the lead in the wearable computing devices industry in 2022, holding a substantial share of 26.5% in the global market.
  • The United States held a significant share of approximately 18.9% in the global wearable computing devices industry in 2022.

How Strong is the Competition in the Wearable Computing Devices Industry?

The competition in the wearable computing devices industry is robust, driven by the continuous influx of innovative products and the presence of established market players.

Companies strive to differentiate themselves through advanced technologies, seamless user experiences, and unique features.

Key players engage in extensive research and development activities to stay ahead of the curve and gain a competitive edge. Additionally, partnerships, collaborations, and strategic alliances are common strategies to expand market reach and offer comprehensive solutions.

As consumer demand for wearable devices continues to grow, the competition intensifies, leading to accelerated innovation, improved product offerings, and an overall dynamic marketplace in the wearable computing devices industry.

Wearable Computing Devices Market by Category

By Product Type:

  • Smartwatches
  • Head Mounted Displays
  • Smart Clothing
  • Ear Worn
  • Fitness Trackers
  • Body Worn Camera
  • Exoskeleton
  • Other

By Application:

  • Firstly, Fitness and Wellness
  • Secondly, Medical and Healthcare
  • Thirdly, Infotainment
  • Additionally, Industrial and Defense
  • Lastly, Other

By Region:

  • In North America
  • Similarly, in Latin America
  • Likewise, in Europe
  • Furthermore, in South Asia
  • Moreover, in East Asia
  • Also, in the Middle East & Africa
  • Lastly, in Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automated CPR Device Market to Surge to USD 255.7 Million by 2034 at a 5.4% of CAGR

Automated CPR Devices Market
Automated CPR Devices Market

The global automated CPR device market is set for notable expansion, with an estimated valuation of USD 150.6 million in 2024. According to recent projections, the market is expected to reach USD 255.7 million by 2034, driven by a compound annual growth rate (CAGR) of 5.4% over the assessment period.

The surge in demand for automated CPR devices is largely attributed to the increasing incidence of cardiovascular diseases (CVD) worldwide. Cardiovascular diseases have seen a dramatic rise in prevalence over the past decade, with global deaths due to CVD climbing from 28.9% in 1990 to 36.3% in 2020. In that year alone, 19.8 million deaths were reported as a result of cardiovascular conditions, underscoring the critical need for effective resuscitation solutions.

The need for automated CPR equipment has increased dramatically as a result of technological developments and growing public awareness of the importance of precise and efficient CPR. Modern devices have intelligent algorithms that adapt to the specific characteristics of the patient’s chest, optimizing compression depth and pace to improve circulation. Furthermore, these devices often come with integrated feedback mechanisms that ensure appropriate CPR administration and support medical practitioners instantly.

The global healthcare systems are under increasing pressure due to the rising prevalence of heart attacks and sudden cardiac arrests. Automated CPR machines have become essential pieces of equipment in emergency rooms, hospitals, and ambulances because they can begin the resuscitation process quickly, providing the patient critical time.

Key Takeaways:

In the historical period, the market captured a valuation of US$ 99.02 million in 2022.

The United States is estimated to dominate the global market by capturing a huge global market share by 2033.

Based on end-user, ambulances are leading the global market by securing a maximum share during the forecast period.

Competitive Landscape:

The automated CPR market is highly consolidated owing to the presence of regional and global market players. Key market players worldwide are employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic mergers and acquisitions and allying with regional distributors to strengthen their supply chain channels. They are also emphasizing faster product approvals, product development, and patenting. New market entrants focus on new product launches to establish their market presence.

Other Key Players in the Global Market are:

  • SunLife Science Inc.
  • ZOLL Medical Corporation
  • Michigan Instruments
  • Physio Control Inc.
  • Brunswick Biomedical Technologies
  • Zhuhai Kindway Medical Science & Technology Co. Ltd
  • CPR Medical Devices Inc.
  • Medtronic Inc.

Recent Developments in the Global Market:

  • Michigan Instruments launched a hand-free automatic CPR device that is lightweight, portable, and helps smooth the transition from manual CPR to automated compressions.
  • ZOLL Medical Corporation introduced a new automated CPR devices system, ‘Autopulse,’ which assists EMS personnel in providing high-quality chest compressions in cramped spaces and steep down stairwells.
  • A new automated CPR device has been launched by Cintas, which assists healthcare professionals by providing real-time CPR feedback and monitoring, enhancing the survival rate of patients.

Automated CPR Devices Market by Category:

By Power Source:

  • Pneumatically Driven CPR Devices
  • Battery-driven CPR Devices
  • Mechanically Actuated And Battery-driven CPR Device

By Device Type:

  • Piston Devices
  • Load Distribution Devices
  • 3D Compression Devices

By End User:

  • EMS
  • Hospitals
  • Ambulances
  • Coronary & Intensive Care Units
  • Cardiac Catheterization Labs
  • Air Med-Evac Units
  • EMT Rescue Units
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

A Old Full  – Report Analysis

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Liver Fibrosis Treatment Market Poised for Exponential Growth, Reaching USD 46.65 Billion by 2033

The global liver fibrosis treatment market, valued at USD 16.43 billion in 2022, is projected to reach an astounding USD 46.65 billion by 2033, growing at an impressive CAGR of 11% during the forecast period from 2023 to 2033, according to a new report by Future Market Insights.

Liver fibrosis, a key indicator of numerous liver disorders, is drawing increased attention from healthcare professionals focused on slowing or preventing liver scarring. While not a disease in itself, liver fibrosis is closely linked to conditions like autoimmune hepatitis, chronic alcoholism, and metabolic storage disorders such as Galactosemia, Wilson disease, and iron-overload syndromes. Additionally, viral and parasitic infections that impair hepatic blood flow further complicate the condition’s management.

Non-alcoholic Steatohepatitis (NASH) as a Growth Catalyst:

One of the major factors driving the liver fibrosis treatment market is the surge in Non-alcoholic Steatohepatitis (NASH) cases. With increasing awareness and investment in NASH treatment, the market is witnessing a significant boost. Private research organizations are pouring resources into developing new therapies targeting liver fibrosis and related fatty liver diseases. This trend is expected to fuel market growth exponentially over the coming decade.

Milestone in Pediatric Hepatitis C Treatment:

A critical breakthrough in liver disease treatment came in April 2019 when the U.S. Food and Drug Administration (FDA) approved AbbVie’s Mavyret, the first confirmed treatment for pediatric Hepatitis C patients across all genotypes. This landmark approval highlights the growing emphasis on innovative treatments for liver fibrosis and associated liver conditions.

Challenges in the Market:

Despite promising growth, the liver fibrosis treatment market faces challenges, particularly the high costs associated with treatment. According to the Centers for Disease Analysis, the U.S. alone spends roughly USD 5 billion annually on liver disease-related healthcare costs, including hospitalizations, screenings, transplants, and chemotherapy. These financial burdens could slow market growth if left unaddressed.

Prevalence of NAFLD and NASH:

Non-alcoholic Fatty Liver Disease (NAFLD), identified by the National Institute of Health as the most common liver disease worldwide, accounts for 25% of global cases. In the U.S., a variant of NAFLD, Non-alcoholic Steatohepatitis (NASH), affects about 5% of the population, underscoring the critical need for advanced liver fibrosis treatments.

Future Outlook:

According to the latest report from Future Market Insights, the liver fibrosis treatment market is on a robust growth trajectory. The report provides an in-depth analysis of market trends and drivers, leveraging the expertise of experienced analysts who employed comprehensive research methodologies.

“With growing incidences of liver disorders, the global liver fibrosis treatment market is expected to grow on an unprecedented note going forward,” says an analyst from Future Market Insights.

Key Takeaways from Liver Fibrosis Treatment Market

  • North America holds the largest market share with a plethora of drug molecules available for improving treatment process with technological development in this region’s rehabilitation. Also, the key participants are into increasingly spending on healthcare. Also, the fact that NAFLD (Non-Alcoholic Fatty Liver Disorder) ends up affecting close to 20% of Canadians can’t be let off.
  • The Asia-Pacific is expected to grow at the quickest rate in the liver fibrosis treatment market on the back of advancements in the medical infrastructure in countries like India, China, and the other South-East Asian economies. Also, there is a growing pool of people contracting Hepatitis C herein.

Stay Ahead with Liver Fibrosis Treatment: Delve into Our Full Report for Extensive Trends and Insights!

Competitive Treatment

  • Aligos Therapeutics Inc., in December 2020, did enter into collaboration with Merck & Co. Inc. for creating a therapy regarding liver fibrosis treatment.
  • Gilead Sciences Inc., in March 2019, did launch HepConnect Program for reducing Hepatitis C Infections in ‘Greater Appalachia’.
  • Beijing Continent Pharmaceutical Co., Ltd., in January 2022, upgraded clinical trial regarding Hydronidone capsules to phase 3. It had finished with an effective Phase II clinical trial in December 2021. The Phase III trial is expected to be completed in June 2024.
  • HepC, under its vector scheme, has its non-pathogenic double-stranded RNA virus behave as one of the expert inducers of anti-viral gene reactions. It is into development of HC001 for curing chronic viral hepatitis caused due to HCV and HBV infections.

What does the Report say?

  • The research study is based on treatment type (Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist, ACE inhibitors, hepatotropic drug, and likewise), condition (chronic liver diseases, Hepatitis C, and non-alcoholic steatohepatitis), and end-user (hospitals, specialty clinics, and likewise).
  • With fatalities out of cirrhosis of liver on the rise, the global liver fibrosis treatment market is bound to grow on an astonishing note going forward.

Key Companies Profiled:

  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • Johnson and Johnson
  • Novartis AG
  • Vertex Pharmaceuticals Incorporated
  • Pfizer Inc.
  • FibroGen, Inc.
  • Inventiva Pharma
  • Pharmaxis Limited

Key Segments Profiled in the Liver Fibrosis Treatment Industry Survey

By Treatment Type:

  • Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist
  • ACE Inhibitors
  • Hepatotropic Drug
  • Others

By Condition:

  • Chronic Liver Diseases
  • Hepatitis C
  • Nonalcoholic Steatohepatitis

By End User:

  • Hospitals
  • Specialty Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

High Content Screening Market Set for Robust Growth, Projected to Reach USD 3 Billion by 2033 at a 5.8% of CAGR

High Content Screening Market
High Content Screening Market

The high content screening (HCS) market is on track to achieve significant growth, with the overall market valuation expected to reach USD 1.6 billion in 2022. Driven by advancements in cellular imaging and drug discovery technologies, the market is projected to experience a robust compound annual growth rate (CAGR) of 5.8% in the coming years.

High content screening, a powerful tool in cellular biology and drug discovery, allows researchers to analyze complex cellular processes and interactions with unprecedented detail. This technology’s capabilities are increasingly being leveraged in various applications, including drug development, toxicology studies, and disease research, fueling market growth.

High content screening technologies, which are pivotal for advanced cellular analysis and drug discovery, are witnessing a surge in demand. This uptick is driven by the increasing adoption of HCS in various applications, including cancer research, drug development, and personalized medicine. The expansion of the market is also fueled by technological advancements and the growing emphasis on high-throughput screening methods that enhance research efficiency and efficacy.

Finding and developing new drugs involves the use of high content screening. The increasing amount of research being done on target identification and validation, along with the ongoing quest for new drug candidates, is predicted to drive an acceleration in the adoption of high content screening over the next few years. Furthermore, it is projected that demand will rise over the course of the projection period as a result of a continued emphasis on manufacturing high-quality and technologically advanced cell imaging systems.

Nevertheless, the COVID-19 pandemic significantly impeded investigations and advancements. The market is anticipated to suffer as a result of this. However, it is anticipated that the market will grow in the upcoming years due to a rise in the amount of money major manufacturers are investing in the creation of cutting-edge cell imaging products.

Key Takeaways

  • The CAGR for the global market over the preceding period was 5.1%.
  • Over the coming decades, the market in India is anticipated to grow at a CAGR of 6.6%.
  • With more than 7.3% of all demand recorded in Europe in 2022, Germany has emerged as a major market.
  • Over the coming decade, the market in China is anticipated to grow at a CAGR of 7.8%.
  • The highest demand for High Content Screenings came from the pharmaceutical and healthcare industries.

“The rising prevalence of multiple infectious diseases with a variety of symptoms raises the demand for innovative treatments. As a result, there will be an increase in biotechnology and pharmaceutical study and development efforts to identify new drug candidates. Imaging technologies are becoming increasingly important in drug discovery and analysis.” says an FMI analyst.

Competitive Landscape:

Key players in the HCS market employ strategies such as mergers and acquisitions, product launches, collaborations, and alliances to expand their businesses.

  • Particle Works, a progressive company that creates and markets cutting-edge particle engineering platforms, declared the release of the Automated Library Synthesis (ALiS) System, a new ground-breaking platform, in November 2022. This innovative platform favors automation in the early stages of the creation of drugs as well as high-throughput evaluation of lipid nanoparticle (LNP) formulations and mRNA candidates.
  • The Twist High Throughput Antibody Production platform, developed by California-based Twist Bioscience Corporation, was made public in April 2022. It allows customers to convert candidate genetic sequences into cleansed antibodies for use in a variety of applications related to screening and therapeutic discovery projects.

Key Companies Profiled: 

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson, and Company
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Merck KGaA
  • Danaher Corporation
  • Yokogawa Electric Corporation
  • BioTek Instruments Inc.

Key Segments Profiled in the High Content Screening Industry Survey:

Product Type:

  • Cell Imaging & Analysis
    • HCS Instruments
      • High-End HCS
      • Mid End HCS
      • Low-End HCS
    • Flow Cytometers
  • Consumables
    • Microplates
    • Reagents & Assay Kits
    • Other Consumables
  • Software
  • Services

Industry:

  • Pharmaceutical & Healthcare
  • Biotechnology
  • Educational Institutions
  • Independent CRO
  • Government Organizations
  • Others

Application:

  • Primary & Secondary Screening
  • Target Identification & Validation
  • Toxicity Studies
  • Compound Profiling
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

A Old Full  – Report Analysis

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Continuous Glucose Monitoring Device Market Set for Remarkable Growth, Poised to Reach USD 16.8 Billion by 2033

The global continuous glucose monitoring device market is on the brink of substantial growth, with new analysis from Future Market Insights revealing a promising future for the sector. Valued at USD 5.5 billion in 2023, the market is projected to reach an impressive USD 16.8 billion by 2033, driven by a compound annual growth rate (CAGR) of 11.9% over the next decade.

A major catalyst for this rapid expansion is the rising demand for sensor components, which are predicted to grow at a CAGR of approximately 11.6% during the forecast period. These sensors, essential to CGM technology, are expected to become the primary revenue generator within the market, benefiting from ongoing technological advancements and the increasing necessity for real-time, precise glucose monitoring.

Continuous glucose monitoring devices have revolutionized diabetes management by offering real-time insights into glucose levels, providing individuals with diabetes an unprecedented understanding of their body’s glucose fluctuations. Unlike traditional finger-stick measurements, CGM devices provide continuous data, empowering users to make more informed decisions about their lifestyle, diet, exercise, and insulin administration.

This technology has been a game-changer for diabetes management, enabling timely interventions and helping individuals maintain better control over their condition. By delivering comprehensive, real-time data, CGM devices play a crucial role in improving the quality of life for millions of people living with diabetes globally.

The ongoing innovation and projected growth within the CGM device market underscore its vital role in the healthcare landscape. As technology continues to evolve, the potential for even greater advancements in diabetes management remains high, offering hope to millions around the world.

Key features and benefits of CGM devices include:

  • Continuous Monitoring: CGM devices provide real-time glucose readings at regular intervals (usually every few minutes) throughout the day and night, enabling users to track their glucose levels without the need for frequent fingerstick testing.
  • Data Trends: CGM devices offer insights into glucose trends, helping users understand how their glucose levels change in response to various factors such as meals, physical activity, and medication.
  • Alerts and Alarms: CGM devices can be programmed to provide alerts and alarms when glucose levels are too high (hyperglycemia) or too low (hypoglycemia), helping users take timely corrective actions to avoid severe complications.
  • Data Sharing: Many CGM devices allow users to share their glucose data with healthcare professionals, caregivers, or family members, enabling remote monitoring and intervention when necessary.
  • Improved Diabetes Management: By having a better understanding of their glucose patterns, users can make informed decisions about insulin dosing, dietary choices, and physical activity to maintain optimal glucose control.

The CGM device market has seen significant growth in recent years due to the increasing prevalence of diabetes, technological advancements, and the growing demand for better diabetes management solutions. The market includes several well-established companies as well as newer entrants, each offering various features, accuracy levels, and form factors to cater to the diverse needs of individuals with diabetes.

Unveil the Continuous Glucose Monitoring Device Surge: Read Our Detailed Report for Essential Trends and Insights!

Key Companies Profiled:

  • A. Menarini Diagnostics
  • Echo Therapeutics, Inc.
  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • GlySens Incorporated
  • Insulet Corporation
  • Johnson & Johnson
  • LifeScan
  • Medtronic plc
  • Medtrum Technologies, Inc.
  • Microchip Technology Inc.
  • Micron Technology Inc.
  • Nemaura Medical, Inc.

Segments Covered in Continuous Glucose Monitoring Device Industry Analysis:

By Component:

  • Transmitters
  • Sensors
  • Receivers

By End-Use:

  • Hospitals
  • Home Care
  • Other End-uses

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube